NASDAQ:CMAX CareMax (CMAX) Stock Price, News & Analysis → The Department of Defense Has a New Drone Contractor (From The Tomorrow Investor) (Ad) Free CMAX Stock Alerts $3.25 +0.16 (+5.18%) (As of 05/7/2024 ET) Add Compare Share Share Today's Range$3.05▼$3.4850-Day Range$2.40▼$14.9052-Week Range$2.23▼$126.00Volume22,351 shsAverage Volume74,440 shsMarket Capitalization$12.35 millionP/E RatioN/ADividend YieldN/APrice Target$45.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get CareMax alerts: Email Address CareMax MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside1,284.6% Upside$45.00 Price TargetShort InterestHealthy9.64% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($22.00) to ($12.99) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.26 out of 5 starsBusiness Services Sector196th out of 313 stocksNursing & Personal Care Facilities Industry2nd out of 4 stocks 3.0 Analyst's Opinion Consensus RatingCareMax has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageCareMax has only been the subject of 1 research reports in the past 90 days.Read more about CareMax's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted9.64% of the float of CareMax has been sold short.Short Interest Ratio / Days to CoverCareMax has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in CareMax has recently decreased by 2.20%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldCareMax does not currently pay a dividend.Dividend GrowthCareMax does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CMAX. Previous Next 0.6 News and Social Media Coverage Search InterestOnly 2 people have searched for CMAX on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows2 people have added CareMax to their MarketBeat watchlist in the last 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, CareMax insiders have not sold or bought any company stock.Percentage Held by Insiders26.90% of the stock of CareMax is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions65.94% of the stock of CareMax is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about CareMax's insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for CareMax are expected to grow in the coming year, from ($22.00) to ($12.99) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of CareMax is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of CareMax is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCareMax has a P/B Ratio of 0.20. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about CareMax's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad InvestorPlaceThe Next Nvidia?The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.Go here now for this breaking story. About CareMax Stock (NASDAQ:CMAX)CareMax, Inc. provides care and chronic disease management services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation; and services to children and adults through Medicaid programs, as well as through commercial insurance plans. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States. It operates multi-specialty medical care centers in Florida, New York, Tennessee, and Texas. The company is headquartered in Miami, Florida.Read More CMAX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CMAX Stock News HeadlinesApril 13, 2024 | investing.comCareMax shares target cut amid liquidity concernsApril 7, 2024 | investorplace.com3 Stocks That Are Actually Worth Shorting for Endless GainsMay 8, 2024 | Manward Press (Ad)Shocking: One AI startup's revenue could surge 4,735%Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner.March 20, 2024 | investing.comEarnings call: CareMax outlines strategic shifts amid sector headwindsMarch 19, 2024 | finance.yahoo.comCareMax, Inc. (NASDAQ:CMAX) Q4 2023 Earnings Call TranscriptMarch 18, 2024 | bizjournals.comHealth care public company cuts staff, closes locations amid $466M lossMarch 18, 2024 | markets.businessinsider.comCareMax Slips To Q4 Loss On Higher Charges, Weak Revenues; Explores Strategic OptionsMarch 18, 2024 | businesswire.comCareMax Reports Fourth Quarter and Full Year 2023 ResultsMay 8, 2024 | Manward Press (Ad)Shocking: One AI startup's revenue could surge 4,735%Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner.March 12, 2024 | prnewswire.comCMAX ALERT: Levi & Korsinsky, LLP Commences an Investigation of CareMax, Inc. (CMAX) f/k/a Deerfield Healthcare Technology Acquisitions Corp. (DFHT)March 11, 2024 | msn.comU.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.12%February 24, 2024 | msn.comCareMax (CMAX) Price Target Increased by 2747.83% to 66.81February 6, 2024 | msn.comCareMax Executes Reverse Stock Split, Adjusts Fiscal YearFebruary 6, 2024 | msn.comCareMax Security Holders Rights Undergo Significant ChangesJanuary 30, 2024 | msn.comCareMax Stockholders Approve Reverse Split VoteJanuary 30, 2024 | msn.comCareMax Announces Reverse Stock Split Effective January 2024January 29, 2024 | finance.yahoo.comCareMax Announces 1-for-30 Reverse Stock SplitJanuary 9, 2024 | markets.businessinsider.comTruist Financial Keeps Their Hold Rating on CareMax (CMAX)December 1, 2023 | markets.businessinsider.comBuy Rating Reaffirmed for CareMax Amid Strategic Shift Toward Free Cash Flow and Long-term GrowthNovember 18, 2023 | msn.comUBS Downgrades CareMax Inc - (CMAX)November 12, 2023 | finance.yahoo.comCareMax, Inc. (NASDAQ:CMAX) Q3 2023 Earnings Call TranscriptNovember 11, 2023 | benzinga.comCareMax Stock (NASDAQ:CMAX), Analyst Ratings, Price Targets, PredictionsNovember 11, 2023 | msn.comPiper Sandler Downgrades CareMax Inc - (CMAX)November 10, 2023 | za.investing.comCareMax cut as Piper Sandler 'cannot continue to recommend the stock'November 9, 2023 | finance.yahoo.comCareMax Reports Third Quarter 2023 ResultsNovember 9, 2023 | finance.yahoo.comCareMax Inc (CMAX) Reports Growth Amidst Challenges in Q3 2023October 25, 2023 | finance.yahoo.comCareMax Schedules Third Quarter 2023 Earnings Conference CallSee More Headlines Receive CMAX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CareMax and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/18/2024Today5/07/2024Next Earnings (Estimated)5/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry Nursing & personal care facilities Sub-IndustryN/A Current SymbolNASDAQ:CMAX CUSIPN/A CIK1813914 Webwww.caremax.com Phone786-360-4768FaxN/AEmployees1,450Year FoundedN/APrice Target and Rating Average Stock Price Target$45.00 High Stock Price Target$60.00 Low Stock Price Target$30.00 Potential Upside/Downside+1,284.6%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($183.0887) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-683,350,000.00 Net Margins-90.98% Pretax Margin-91.09% Return on Equity-35.76% Return on Assets-15.93% Debt Debt-to-Equity Ratio0.35 Current Ratio0.42 Quick Ratio0.42 Sales & Book Value Annual Sales$751.10 million Price / Sales0.02 Cash Flow$108.33 per share Price / Cash Flow0.03 Book Value$16.42 per share Price / Book0.20Miscellaneous Outstanding Shares3,800,000Free Float2,780,000Market Cap$12.35 million OptionableOptionable Beta0.87 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Carlos A. de Solo (Age 45)Co-Founder, President, CEO & Director Comp: $1.3MMr. Kevin C. Wirges (Age 44)Executive VP, CFO & Treasurer Comp: $705.05kMr. Alberto R. de Solo (Age 47)Executive VP & COO Comp: $905.35kMr. Erick Anthony Fernandez (Age 45)Chief Accounting Officer Mr. Mark LlorenteChief Administrative Officer & Head of MSO OperationsRoger OuSVP of Finance & Investor RelationsMs. Meredith LongsworthSenior VP, General Counsel & SecretaryMs. Teresa McMeansChief Compliance OfficerMs. Regla WuilchristChief People OfficerMr. Niberto Moreno M.D.Chief Medical Officer & President of Caremax MSOMore ExecutivesKey CompetitorsStarbox GroupNASDAQ:STBX36KrNASDAQ:KRKRAdvanced Health IntelligenceNASDAQ:AHIExela TechnologiesNASDAQ:XELANauticus RoboticsNASDAQ:KITTView All CompetitorsInstitutional OwnershipCoronation Fund Managers Ltd.Sold 1,207,721 shares on 5/3/2024Ownership: 1.096%Mirae Asset Global Investments Co. Ltd.Bought 27,002 shares on 5/1/2024Ownership: 0.711%Perceptive Advisors LLCSold 144,273 shares on 2/26/2024Ownership: 98.377%Eminence Capital LPBought 539,544 shares on 2/14/2024Ownership: 278.734%CastleKnight Management LPBought 246,800 shares on 2/14/2024Ownership: 10.019%View All Institutional Transactions CMAX Stock Analysis - Frequently Asked Questions Should I buy or sell CareMax stock right now? 3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CareMax in the last year. There are currently 3 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CMAX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CMAX, but not buy additional shares or sell existing shares. View CMAX analyst ratings or view top-rated stocks. What is CareMax's stock price target for 2024? 3 brokers have issued 12 month target prices for CareMax's stock. Their CMAX share price targets range from $30.00 to $60.00. On average, they anticipate the company's share price to reach $45.00 in the next twelve months. This suggests a possible upside of 1,284.6% from the stock's current price. View analysts price targets for CMAX or view top-rated stocks among Wall Street analysts. How have CMAX shares performed in 2024? CareMax's stock was trading at $14.9460 at the start of the year. Since then, CMAX shares have decreased by 78.3% and is now trading at $3.25. View the best growth stocks for 2024 here. Are investors shorting CareMax? CareMax saw a increase in short interest in March. As of March 31st, there was short interest totaling 231,700 shares, an increase of 5.3% from the March 15th total of 220,100 shares. Based on an average daily volume of 77,600 shares, the short-interest ratio is currently 3.0 days. Approximately 9.9% of the company's stock are short sold. View CareMax's Short Interest. When is CareMax's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024. View our CMAX earnings forecast. How were CareMax's earnings last quarter? CareMax, Inc. (NASDAQ:CMAX) announced its quarterly earnings results on Monday, March, 18th. The company reported ($25.82) earnings per share for the quarter. The company had revenue of $151.84 million for the quarter, compared to analysts' expectations of $191.31 million. CareMax had a negative trailing twelve-month return on equity of 35.76% and a negative net margin of 90.98%. When did CareMax's stock split? CareMax shares reverse split before market open on Thursday, February 1st 2024. The 1-30 reverse split was announced on Thursday, February 1st 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, February 1st 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. Who are CareMax's major shareholders? CareMax's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Coronation Fund Managers Ltd. (1.10%), Mirae Asset Global Investments Co. Ltd. (0.71%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Bryan Cho and Jose Ramon Rodriguez. View institutional ownership trends. How do I buy shares of CareMax? Shares of CMAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CMAX) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorAI “wealth window” is closing June 25thParadigm Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsStock-Picking AI Predicts #1 Stock of 2024AltimetryElon Musk Secret Crypto Plot ExposedCrypto 101 MediaThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyThe AI Stock that’s Disrupting Every IndustryStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CareMax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.